Pharming Group N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
17 mei 2010 - 12:03
Statutaire naam
Pharming Group N.V.
Titel
PHARMING INITIATES DIVESTMENT OF DNAGE
Bericht
Leiden, The Netherlands, May 17, 2010. Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) announces today that it has initiated the process to reduce its financial interest in its wholly-owned subsidiary DNage BV (“DNage”) in order to reduce the cash need and fully focus on the commercialization of its lead product Rhucin®. As a first step of this process, the Company has reached an agreement with the former shareholders of DNage from whom DNage was acquired by Pharming in 2006.
Gerelateerde downloads
Datum laatste update: 06 februari 2025